SCHEMBL9044255

SCHEMBL9044255

O=S(=O)(Nc1ncnc(Cl)c1-c1ccc(Cl)cc1)c1ccc2ccccc2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.56
MEN1 O00255 3/20 0.56
KMT2A Q03164 3/20 0.56
HPGD P15428 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
EDNRB P24530 2/20 0.52
EDNRA P25101 2/20 0.52
FBP1 P09467 2/20 0.50
TSHR P16473 1/20 0.47
POLB P06746 2/20 0.47
KDM4E B2RXH2 1/20 0.47
LMNA P02545 1/20 0.47
MAPT P10636 1/20 0.47
HTT P42858 1/20 0.47
ESR2 Q92731 1/20 0.47
KAT6A Q92794 1/20 0.46
SCN5A Q14524 1/20 0.45
SCN9A Q15858 1/20 0.45
GLO1 Q04760 1/20 0.44
TDP1 Q9NUW8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9045384 0.91 ALDH1A1 (0.54) ALDH1A1MEN1KMT2AHPGDSMN1; SMN2
SCHEMBL9047067 0.85 EDNRB (0.59) ALDH1A1MEN1KMT2AEDNRBEDNRA
SCHEMBL9044301 0.84 KDM1A (0.54) EDNRBEDNRAFBP1TSHRKDM4E
SCHEMBL9045266 0.83 EDNRA (0.79) ALDH1A1MEN1KMT2AHPGDSMN1; SMN2
SCHEMBL9046070 0.82 EDNRB (0.53) ALDH1A1MEN1KMT2ASMN1; SMN2EDNRB
SCHEMBL9046378 0.81 EDNRA (0.57) ALDH1A1MEN1KMT2AEDNRBEDNRA
SCHEMBL9043560 0.81 EDNRA (0.59) ALDH1A1MEN1KMT2ASMN1; SMN2EDNRB
SCHEMBL9046709 0.81 ALDH1A1 (0.60) ALDH1A1MEN1KMT2AEDNRBEDNRA
SCHEMBL9495682 0.81 EDNRB (0.59) ALDH1A1MEN1KMT2AEDNRBEDNRA
SCHEMBL9045764 0.81 EDNRB (0.59) ALDH1A1MEN1KMT2AEDNRBEDNRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0510526-B1 Use of sulfonamides as drug and new sulfonamides HOFFMANN LA ROCHE (CH) 1996-12-04 EP disclosed
US-5270313-A Treatment of circulatory disorders HOFFMANN-LA ROCHE INC. (US) 1993-12-14 US disclosed
EP-0510526-A1 Use of sulfonamides as drug and new sulfonamides F.HOFFMANN-LA ROCHE & CO. AKTIENGESELLSCHAFT (CH) 1992-10-28 EP disclosed